; (F) provide for the stewardship of qualified pandemic or epidemic products developed pursuant to the strategy; (G) define criteria so that scarce funds are allocated to advance qualified pandemic or epidemic products that can achieve the greatest positive impact on human health, including unprecedented approaches to preventing, treating, and diagnosing infectious diseases; (H) consider approaches including securing contracts with the private sector, entering into public-private partnerships, implementing alternative payment models, and streamlining regulatory approval processes; and (I) be synchronized with United States pandemic preparedness priorities, such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB). (b) Arrangements with foreign countries and multilateral organizations The Secretary of Health and Human Services, in consultation with the Secretary of State, shall seek to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities to implement the strategy under subsection (a). (c) Definition In this section: (1) The term priority pathogens means pathogens identified in the latest Centers for Disease Control and Prevention Antimicrobial Threats Report, the World Health Organization Global Priority Pathogens List, or a successor report or list. (2) The term qualified pandemic or epidemic product has the meaning given to such term in section 319F–3 of the Public Health Service Act ( 42 U.S.C. 247d–6b ).